Clive Ballard Selected Research

Rivastigmine (Exelon)

8/2012	Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment.
7/2007	Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease.
11/2006	Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology.
4/2005	Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Clive Ballard Research Topics

Disease

140	Dementia (Dementias) 04/2024 - 02/2002
80	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 06/2003
43	Cognitive Dysfunction 04/2024 - 11/2002
31	Parkinson Disease (Parkinson's Disease) 04/2024 - 07/2009
24	Psychotic Disorders (Schizoaffective Disorder) 04/2024 - 08/2008
14	Hallucinations (Hallucination) 04/2024 - 12/2004
14	Pain (Aches) 10/2023 - 07/2011
14	Stroke (Strokes) 07/2023 - 03/2005
9	Lewy Body Disease (Lewy Body Dementia) 11/2022 - 01/2005
6	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2024 - 12/2004
5	Disease Progression 04/2024 - 09/2014
4	COVID-19 12/2023 - 12/2021
4	Infections 12/2020 - 10/2015
4	Delirium 11/2020 - 10/2010
3	Amyloid Plaque 05/2023 - 07/2015
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2019
3	Inflammation (Inflammations) 01/2022 - 09/2019
3	Atrophy 01/2021 - 11/2007
3	Ischemic Stroke 01/2017 - 11/2013
2	Human Influenza (Influenza) 11/2023 - 01/2020
2	Prodromal Symptoms 01/2023 - 01/2014
2	Constipation 01/2022 - 01/2021
2	Synucleinopathies 01/2021 - 10/2010
2	Urinary Tract Infections (Urinary Tract Infection) 01/2021 - 01/2018
2	Venous Thromboembolism 11/2020 - 01/2020
2	Neurobehavioral Manifestations 01/2017 - 10/2011
2	Hypertension (High Blood Pressure) 01/2016 - 06/2003
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2016 - 11/2006
2	Down Syndrome (Down's Syndrome) 10/2013 - 02/2012
2	Orthostatic Hypotension (Postural Hypotension) 01/2009 - 11/2002

Drug/Important Bio-Agent (IBA)

45	Antipsychotic Agents (Antipsychotics)IBA 12/2023 - 02/2002
24	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2008
18	Amyloid (Amyloid Fibrils)IBA 11/2023 - 01/2005
16	Memantine (Namenda)FDA Link 01/2023 - 11/2006
16	Cholinesterase Inhibitors (Anticholinesterases)IBA 11/2022 - 05/2003
13	pimavanserinIBA 04/2024 - 02/2014
12	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2010
8	SynucleinsIBA 11/2023 - 10/2010
8	Cholinergic Agents (Cholinergics)IBA 01/2020 - 06/2003
8	Antidepressive Agents (Antidepressants)IBA 09/2017 - 08/2008
7	Apolipoproteins E (ApoE)IBA 04/2023 - 04/2008
7	Donepezil (Aricept)FDA LinkGeneric 01/2019 - 11/2006
6	Analgesics (Analgesic Drugs)IBA 01/2019 - 04/2012
5	Mirtazapine (Rexer)FDA LinkGeneric 10/2023 - 07/2011
5	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2018 - 07/2011
5	ButyrylcholinesteraseIBA 01/2013 - 06/2003
4	LipidsIBA 11/2023 - 11/2013
4	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2020 - 01/2010
4	Buprenorphine (Subutex)FDA LinkGeneric 01/2018 - 07/2011
4	Rivastigmine (Exelon)FDA LinkGeneric 08/2012 - 04/2005
3	BenzodiazepinesIBA 01/2022 - 11/2020
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 01/2019
3	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 01/2012
3	Hypnotics and Sedatives (Sedatives)IBA 01/2021 - 06/2003
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2016
3	ApolipoproteinsIBA 01/2019 - 04/2008
3	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2019 - 04/2008
3	LDL CholesterolIBA 01/2017 - 11/2013
3	CholesterolIBA 01/2017 - 11/2015
2	brexpiprazoleIBA 04/2024 - 12/2023
2	Anthocyanins (Anthocyanin)IBA 01/2023 - 01/2020
2	Coenzyme A (CoA)IBA 01/2023 - 01/2022
2	Peptides (Polypeptides)IBA 01/2022 - 01/2015
2	Zolpidem (Ambien)FDA LinkGeneric 01/2021 - 11/2020
2	Protein Isoforms (Isoforms)IBA 01/2021 - 01/2011
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2012
2	zaleplon (Sonata)FDA LinkGeneric 01/2021 - 11/2020
2	zopiclone (Zop)IBA 01/2021 - 11/2020
2	Liraglutide FDA Link 01/2020 - 01/2019
2	Opioid Analgesics (Opioids)IBA 01/2019 - 04/2012
2	(2- (6- fluoro- 1H- indol- 3- yl)- ethyl)- (3- (2,2,3,3- tetrafluoropropoxy)benzyl)amineIBA 01/2019 - 01/2018
2	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 11/2018 - 01/2018
2	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2018 - 01/2018
2	ZincIBA 01/2018 - 02/2015
2	NeurograninIBA 01/2017 - 11/2016
2	oxidized low density lipoproteinIBA 01/2017 - 11/2013
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2017 - 06/2008
2	Dextromethorphan (Racemethorphan)FDA LinkGeneric 02/2016 - 09/2015
2	Quinidine (Chinidin)FDA LinkGeneric 02/2016 - 09/2015
2	Pemetrexed (MTA)FDA Link 03/2015 - 11/2007
2	Vitamin E FDA LinkGeneric 08/2014 - 11/2006
2	Morphine (MS Contin)FDA LinkGeneric 07/2014 - 07/2011
2	Sertraline (Zoloft)FDA LinkGeneric 02/2013 - 07/2011
2	alpha-SynucleinIBA 10/2010 - 03/2010
2	hydroxide ionIBA 01/2009 - 11/2002
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2006 - 12/2004
1	Influenza Vaccines (Influenza Vaccine)FDA Link 11/2023
1	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 11/2023

Therapy/Procedure

24	Therapeutics 01/2023 - 06/2003
16	Home Nursing (Nursing, Home) 04/2024 - 04/2006
8	Activities of Daily Living (ADL) 12/2022 - 01/2006
7	Cognitive Training 04/2024 - 10/2011
5	Drug Therapy (Chemotherapy) 01/2021 - 09/2009
4	Institutionalization (Institutionalized Persons) 06/2020 - 07/2009
3	Pain Management 10/2023 - 07/2014
3	Aromatherapy 01/2011 - 11/2006
2	Precision Medicine 04/2024 - 12/2020
2	Inappropriate Prescribing 01/2022 - 01/2021
2	Transdermal Patch 07/2014 - 07/2011
2	Immunotherapy 01/2014 - 06/2012